Authors

• Karolina Wosik
• John Woolcott (ORCID: https://orcid.org/0000-0001-7445-8696)
• Bruce E. Sands (ORCID: https://orcid.org/0000-0001-5762-5042)
• C C Smith
• Martina Goetsch
• Yvette Leung (ORCID: https://orcid.org/0000-0002-8699-4370)
• Julián Panés (ORCID: https://orcid.org/0000-0002-4971-6902)
• David T. Rubin (ORCID: https://orcid.org/0000-0001-5647-1723)
• K Gecse (ORCID: https://orcid.org/0000-0003-4830-142X)
• Wenjin Wang (ORCID: https://orcid.org/0000-0002-8790-5464)
• Stefan Schreiber

Institutions

• University of British Columbia (CA)
• Pfizer (United States) (US)
• Christian-Albrechts-Universität zu Kiel (DE)
• University of Chicago (US)
• Pfizer (Switzerland) (CH)
• University Hospital Schleswig-Holstein (DE)
• Hospital Clínic de Barcelona (ES)
• Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES)
• Amsterdam University Medical Centers (NL)
• Pfizer (Canada) (CA)
• Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
• University of Amsterdam (NL)
• University of Lübeck (DE)
• Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal

Journal of Crohn s and Colitis

Published

2024-09-22

DOI

https://doi.org/10.1093/ecco-jcc/jjae150

Citations

4

Primary Topic

Liver Diseases and Immunity

Type

article

Field-Weighted Citation Impact

1.48

Funders

• Pfizer
• American College of Gastroenterology
• United European Gastroenterology